BC is classified into subtypes based on estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2/ERBB2), and proliferative index (Ki-67) expression. This evidence concerns the gene ERBB2 and breast cancer.